Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 251362, 7 pages
http://dx.doi.org/10.1155/2012/251362
Research Article

Betulinic Acid Inhibits Growth of Cultured Vascular Smooth Muscle Cells In Vitro by Inducing Arrest and Apoptosis

1Institute of Bioscience, Universiti Putra Malaysia, Selangor, Serdang, Malaysia
2Faculty of Agriculture and Biotechnology, Universiti Sultan Zainal Abidin, Kampus Kota, Jalan Sultan Mahmud, 20400 Kuala Terengganu, Malaysia
3Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Selangor, 43400 Serdang, Malaysia
4Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Selangor, 43400 Serdang, Malaysia

Received 22 February 2012; Revised 16 August 2012; Accepted 29 August 2012

Academic Editor: Virginia S. Martino

Copyright © 2012 Raja Kumar Vadivelu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. J. Dzau, R. C. Braun-Dullaeus, and D. G. Sedding, “Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies,” Nature Medicine, vol. 8, no. 11, pp. 1249–1256, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Ligthart, F. Vlemmix, N. Dendukuri, and J. M. Brophy, “The cost-effectiveness of drug-eluting stents: a systematic review,” CMAJ, vol. 176, no. 2, pp. 199–205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Grube, U. Gerckens, and L. Buellesfeld, “Drug-eluting stents: clinical experiences and perspectives,” Minerva Cardioangiologica, vol. 50, no. 5, pp. 469–473, 2002. View at Google Scholar · View at Scopus
  4. S. J. Rhee, K. H. Yun, S. R. Lee et al., “Drug-eluting Stent thrombosis during perioperative period,” International Heart Journal, vol. 49, no. 2, pp. 135–142, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. H. Shishehbor, R. Amini, R. E. Raymond et al., “Safety and efficacy of overlapping sirolimus-eluting versus paclitaxel-eluting stents,” American Heart Journal, vol. 155, no. 6, pp. 1075–1080, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. J. E. Sousa, M. A. Costa, A. C. Abizaid et al., “Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up,” Circulation, vol. 104, no. 17, pp. 2007–2011, 2001. View at Google Scholar · View at Scopus
  7. K. M. Chan, N. F. Rajab, M. H. A. Ishak et al., “Goniothalamin induces apoptosis in vascular smooth muscle cells,” Chemico-Biological Interactions, vol. 159, no. 2, pp. 129–140, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Yogeeswari and D. Sriram, “Betulinic acid and its derivatives: a review on their biological properties,” Current Medicinal Chemistry, vol. 12, no. 6, pp. 657–666, 2005. View at Google Scholar · View at Scopus
  9. Y. Yun, S. Han, E. Park et al., “Immunomodulatory activity of betulinic acid by producing pro-inflammatory cytokines and activation of macrophages,” Archives of pharmacal research, vol. 26, no. 12, pp. 1087–1095, 2003. View at Google Scholar · View at Scopus
  10. R. H. Cichewicz and S. A. Kouzi, “Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection,” Medicinal Research Reviews, vol. 24, no. 1, pp. 90–114, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. J. C. Steele, D. C. Warhurst, G. C. Kirby, and M. S. Simmonds, “In vitro and in vivo evaluation of betulinic acid as an antimalarial,” Phytotherapy Research, vol. 2, pp. 115–119, 1999. View at Google Scholar
  12. R. Mukherjee, M. Jaggi, P. Rajendran et al., “Betulinic acid and its derivatives as anti-angiogenic agents,” Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 9, pp. 2181–2184, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Takada and B. B. Aggarwal, “Betulinic acid suppresses carcinogen-induced NF-κB activation through inhibition of IκBα kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9,” Journal of Immunology, vol. 171, no. 6, pp. 3278–3286, 2003. View at Google Scholar · View at Scopus
  14. N. Sawada, K. Kataoka, K. Kondo et al., “Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice,” British Journal of Cancer, vol. 90, no. 8, pp. 1672–1678, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Fulda, I. Jeremias, H. H. Steiner, T. Pietsch, and K. M. Debatin, “Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells,” International Journal of Cancer, vol. 82, pp. 435–441, 1999. View at Google Scholar
  16. S. Fulda, I. Jeremias, T. Pietsch, and K. M. Debatin, “Betulinic acid: a new chemotherapeutic agent in the treatment of neuroectodermal tumors,” Klinische Padiatrie, vol. 211, no. 4, pp. 319–322, 1999. View at Google Scholar · View at Scopus
  17. S. Fulda, G. Scaffidi, S. A. Susin et al., “Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid,” The Journal of Biological Chemistry, vol. 273, no. 51, pp. 33942–33948, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. N. B. Alitheen, A. R. Mashitoh, S. K. Yeap, M. Shuhaimi, A. Abdul Manaf, and L. Nordin, “Cytotoxic effect of damnacanthal, nordamnacanthal, zerumbone and betulinic acid isolated from Malaysian plant sources,” International Food Research Journal, vol. 17, no. 3, pp. 711–719, 2010. View at Google Scholar · View at Scopus
  19. N. H. Faujan, N. B. Alitheen, S. K. Yeap, A. M. Ali, A. H. Muhajir, and F. B. H. Ahmad, “Cytotoxic effect of betulinic acid and betulinic acid acetate isolated from Melaleuca cajuput on human myeloid leukemia (HL-60) cell line,” African Journal of Biotechnology, vol. 9, no. 38, pp. 6387–6396, 2010. View at Google Scholar · View at Scopus
  20. J. J. Yoon, Y. J. Lee, J. S. Kim, D. G. Kang, and H. S. Lee, “Betulinic acid inhibits high glucose-induced vascular smooth muscle cells proliferation and migration,” Journal of Cellular Biochemistry, vol. 111, no. 6, pp. 1501–1511, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. J. Yoon, Y. J. Lee, D. G. Kang, J. S. Kim, and H. S. Lee, “Inhibitory effect of betulinic acid on TNF-α-induced adhesion molecule and its related signaling,” The FASEB Journal, vol. 23, p. 937.10, 2009, (Meeting Abstract Supplement). View at Google Scholar
  22. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983. View at Google Scholar · View at Scopus
  23. P. R. Heaton, R. Ransley, C. J. Charlton et al., “Application of single-cell gel electrophoresis (comet) assay for assessing levels of DNA damage in canine and feline leukocytes,” Journal of Nutrition, vol. 132, no. 6, pp. 15985–16035, 2002. View at Google Scholar · View at Scopus
  24. V. Zuco, R. Supino, S. C. Righetti et al., “Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells,” Cancer Letters, vol. 175, no. 1, pp. 17–25, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. G. I. Salti, J. V. Kichina, T. K. Das Gupta et al., “Betulinic acid reduces ultraviolet-C-induced DNA breakage in congenital melanocytic naeval cells: evidence for a potential role as a chemopreventive agent,” Melanoma Research, vol. 11, no. 2, pp. 99–104, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Zhou, J. Ahn, S. H. Wilson, and C. Prives, “A role for p53 in base excision repair,” The EMBO Journal, vol. 20, no. 4, pp. 914–923, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Kaina, “DNA damage-triggered apoptosis: critical role of DNA repair, double-strand breaks, cell proliferation and signaling,” Biochemical Pharmacology, vol. 66, no. 8, pp. 1547–1554, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Rzeski, A. Stepulak, M. Szymański et al., “Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells,” Naunyn-Schmiedeberg's archives of pharmacology, vol. 374, no. 1, pp. 11–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. S. I. Wada and R. Tanaka, “Betulinic acid and its derivatives, potent DNA topoisomerase II inhibitors, from the bark of Bischofia javanica,” Chemistry and Biodiversity, vol. 2, no. 5, pp. 689–694, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. J. C. Wang, “Cellular roles of DNA topoisomerases: a molecular perspective,” Nature Reviews Molecular Cell Biology, vol. 3, no. 6, pp. 430–440, 2002. View at Publisher · View at Google Scholar · View at Scopus